BIOFABRI
Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
Bharat Biotech starts clinical trials of TB jabThe only vaccine in use today--BCG (Bacillus Calmette and Guerin)--is an attenuated variant of the bovine TB pathogen. This is more than a ...
Bharat Biotech begins clinical trials of TB vaccine on adults in IndiaBharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine Mtbvac on adults in India. Developed by the Spa...
Bharat Biotech enters into partnership with Biofabri for TB vaccineThe new TB vaccine, 'MTBVAC', is being manufactured and developed by Biofabri, in close collaboration with the University of Zaragoza, IAVI...
Load More